Top compounds associated with response to TCTA


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.022 0.5
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.5
mRNA QL-VIII-58 GDSC1000 pan-cancer AAC -0.034 0.5
mRNA Tamoxifen CTRPv2 pan-cancer AAC -0.028 0.5
mRNA SR8278 CTRPv2 pan-cancer AAC -0.097 0.5
mRNA Irinotecan FIMM pan-cancer AAC -0.08 0.5
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA serdemetan FIMM pan-cancer AAC 0.11 0.5
mRNA ZSTK474 GDSC1000 pan-cancer AAC 0.022 0.5
Download CSV